Modulation of cardiac aldosterone synthase and type I mineralocorticoid receptor expression in experimental chronic heart failure

被引：0
作者：
Christ, M
Kellner, M
Wehling, M
Lombés, M
Fraccarollo, D
Ertl, G
Bauersachs, J
机构：
[1] Klinikum Mannheim, Inst Clin Pharmacol, Mannheim, Germany
[2] Fac Med Xavier Bichat, INSERM, U478, Paris, France
[3] Med Universitatsklin, Wurzburg, Germany
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1362
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [21] Mineralocorticoid receptor antagonism decreases cardiac mass in Ang II-treated wild type but not aldosterone synthase-deficient mice
    Luther, James M.
    Wang, Zuofei
    Ma, Ji
    Makhanova, Natalia
    Kim, Hyung-Suk
    Brown, Nancy J.
    HYPERTENSION, 2007, 50 (04) : E88 - E88
  • [22] Association of Aldosterone Concentration and Mineralocorticoid Receptor Genotype with Potassium Response to Spironolactone in Patients with Heart Failure
    Cavallari, Larisa H.
    Groo, Vicki L.
    Viana, Marlos A. G.
    Dai, Yang
    Patel, Shitalben R.
    Stamos, Thomas D.
    PHARMACOTHERAPY, 2010, 30 (01): : 1 - 9
  • [23] Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure
    Kasama, Shu
    Toyama, Takuji
    Sumino, Hiroyuki
    Kumakura, Hisao
    Takayama, Yoshiaki
    Minami, Kazutomo
    Ichikawa, Shuichi
    Matsumoto, Naoya
    Sato, Yuichi
    Kurabayashi, Masahiko
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (01) : 244 - 249
  • [24] ALDOSTERONE RECEPTOR HYPOSENSITIVITY DURING CHRONIC CARDIAC-FAILURE (ICC)
    SANCHEZ, G
    POSADAS, C
    BOYER, JL
    DALLO, L
    GUZMAN, J
    SERRANO, PA
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1981, 33 (01): : 145 - 146
  • [25] Interactions of Enhanced Urocortin 2 and Mineralocorticoid Receptor Antagonism in Experimental Heart Failure
    Rademaker, Miriam T.
    Charles, Christopher J.
    Nicholls, M. Gary
    Richards, A. Mark
    CIRCULATION-HEART FAILURE, 2013, 6 (04) : 825 - 832
  • [26] Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: Contemporary concepts
    Mehra, MR
    Uber, PA
    Potluri, S
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (05) : 267 - 275
  • [27] Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade
    Martin-Fernandez, Beatriz
    de las Heras, Natalia
    Valero-Munoz, Maria
    Ballesteros, Sandra
    Yao, Yi-Zhou
    Stanton, Peter G.
    Fuller, Peter J.
    Lahera, Vicente
    PLOS ONE, 2014, 9 (10):
  • [28] PREREQUISITE FOR CARDIAC ALDOSTERONE ACTION - MINERALOCORTICOID RECEPTOR AND 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN THE HUMAN HEART
    LOMBES, M
    ALFAIDY, N
    EUGENE, E
    LESSANA, A
    FARMAN, N
    BONVALET, JP
    CIRCULATION, 1995, 92 (02) : 175 - 182
  • [29] Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
    Tereshchenko, S. N.
    Zhirov, I. V.
    Osmolovskaya, Yu F.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (12) : 137 - 143
  • [30] CARDIAC LYMPHATICS IN EXPERIMENTAL CHRONIC CONGESTIVE HEART FAILURE
    UHLEY, HN
    LEEDS, SE
    SAMPSON, JJ
    FRIEDMAN, M
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1969, 131 (02): : 379 - &
12345